We invest in the emerging technology infrastructure of pediatric health
Where Lifelong Health Begins
Pediatrics is entering a period of rapid technological transformation.
AI-driven diagnostics, precision therapeutics, home-based care platforms, and specialized medical devices are reshaping how medicine is delivered in the earliest stages of life.
These innovations are not incremental. They redefine how health trajectories are shaped across decades.
Fractal invests early in the companies building this new infrastructure.
We partner with founders developing deep-technology solutions and provide active capital, clinical insight, and strategic support to help them scale.

Our current areas of focus:
PEDIATRIC CHRONIC CONDITIONS
$300B Market
Asthma, mental health disorders, diabetes, obesity, hypertension, and related conditions affect nearly 40% of children with the majority persisting into adulthood and driving lifelong healthcare spend.
This sustained demand, long duration of care, and multidecade cost trajectory create substantial opportunity for scalable innovation and durable capital returns.
MATERNAL-FETAL HEALTH
$160B Market
Access gaps, placental therapeutics, fetal and neonatal monitoring, and early-life care remain undercapitalized despite worsening outcomes: maternal mortality up 89% since 2018, infant mortality up 10% since 2022, and 1 in 12 women lacking access to care.
These are large, high-urgency, structurally underbuilt markets within healthcare that offer opportunity for capital-efficient innovation and upsized returns.
Digital, AI, Software
We invest in tools that modernize pediatric care delivery and models that align incentives, improve affordability, and unlock scalable distribution.
Diagnostics
As provider shortages intensify, technology-enabled care becomes not optional but foundational infrastructure.
Therapeutics
We back proprietary science and platform technologies.
Devices
Children are not small adults. We support companies developing pediatric-specific devices — not retrofits.
Consumer Space
We invest in consumer health platforms where pediatric need intersects with scalable demand.